Gilead Sciences (GILD) Tax Provisions (2009 - 2026)

Gilead Sciences has reported Tax Provisions for 18 years, with the latest figure at $559.0 million in Q1 2026.

• For the quarter ending Q1 2026, Tax Provisions rose 67.37% year-over-year to $559.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 billion (up 35.58% YoY), and the FY2025 full-year result was $1.3 billion, up 509.48% from the prior year.
• Tax Provisions for Q1 2026 stood at $559.0 million, up from -$450.0 million in the prior quarter.
• The five-year high for Tax Provisions was $646.0 million in Q3 2022, with the low at -$450.0 million in Q4 2025.
• Historically, Tax Provisions has averaged $247.5 million across 5 years, with a median of $368.0 million in 2022.
• Annual changes were most pronounced in 2024 — Tax Provisions sank 303.42% — and 2025, when it soared 298.32%.
• Gilead Sciences' Tax Provisions stood at $398.0 million in 2022, then sank by 40.45% to $237.0 million in 2023, then soared by 62.45% to $385.0 million in 2024, then sank by 216.88% to -$450.0 million in 2025, then surged by 224.22% to $559.0 million in 2026.
• The last three Tax Provisions figures came in at $559.0 million (Q1 2026), -$450.0 million (Q4 2025), and $589.0 million (Q3 2025), per Business Quant data.